Does Wegovy Affect Bone Strength?

Wegovy (semaglutide) has helped thousands of people lose weight safely and effectively, but as its use becomes more widespread, many people are asking an important question:

Can Wegovy affect bone density or increase the risk of broken bones?

Can Wegovy weaken our bones?

The short answer is reassuring. Current clinical evidence does not show that Wegovy directly weakens bones or increases the risk of fractures. However, significant weight loss can influence bone health in some individuals, particularly if nutritional intake or muscle mass is not maintained during treatment.

Here's what the latest research tells us.

Does Wegovy directly weaken bones?

At present, there is no convincing evidence that semaglutide has a harmful effect on bone tissue.

In fact, scientists have identified GLP-1 receptors on cells involved in bone remodelling, including:

• Osteoblasts, which build new bone.

• Osteoclasts, which remove old bone.

Laboratory research suggests that GLP-1 medicines may actually support healthy bone metabolism by reducing bone breakdown and encouraging bone formation. While these findings are encouraging, laboratory studies do not always predict what happens in people, so longer-term clinical research is continuing.

The evidence available so far suggests that semaglutide itself is unlikely to damage bone strength.

What do clinical studies show?

Several high-quality systematic reviews have analysed data from thousands of patients taking GLP-1 receptor agonists, including semaglutide.

The findings have been consistent:

• No significant increase in fracture risk.

• No evidence that semaglutide causes osteoporosis.

• Small improvements in bone mineral density have been reported at the spine and hip in some studies.

• Bone turnover markers suggest that normal bone remodelling is maintained during treatment.

Although researchers continue to monitor patients over longer periods, current evidence is reassuring and does not indicate that Wegovy directly harms bone health.

Why can weight loss affect bone health?

The medication itself is only one part of the picture.

When people lose a substantial amount of weight, the body undergoes several changes that can influence bone density regardless of whether the weight loss is achieved through medication, diet or bariatric surgery.

Reduced mechanical loading

Bones respond to the forces placed upon them.

Carrying more body weight places greater stress on the skeleton, encouraging bones to remain strong. As weight decreases, bones experience less mechanical loading, meaning they receive less stimulation to maintain bone mass.

This is a normal physiological response and is not unique to Wegovy.

What can put our bones at risk?

Could eating less affect bone strength?

One of Wegovy's main benefits is reducing appetite, making it easier to consume fewer calories.

However, eating significantly less can sometimes make it harder to obtain enough nutrients needed to support healthy bones.

Protein

Protein is essential for maintaining both muscle and bone.

If protein intake is too low during weight loss, muscle mass may decline more rapidly, reducing the forces that help stimulate healthy bone maintenance.

Calcium

Calcium is one of the main minerals found in bone.

Insufficient dietary calcium over a prolonged period may cause the body to draw calcium from the skeleton to maintain normal blood calcium levels.

Vitamin D

Vitamin D helps the body absorb calcium efficiently.

As vitamin D deficiency is already common across the UK, particularly during autumn and winter, maintaining adequate levels becomes even more important during weight loss.

Muscle plays an important role

Healthy muscles protect healthy bones.

Research has shown that some of the weight lost during treatment with GLP-1 medicines comes from lean body mass as well as fat.

Maintaining muscle through resistance exercise and adequate protein intake helps to:

• support bone strength

• improve balance

• reduce the likelihood of falls

• maintain long-term mobility

For this reason, exercise should always be considered an important part of any medically supervised weight loss programme.

Does Wegovy increase the risk of fractures?

Based on current research, there is no evidence that Wegovy increases fracture risk.

Large clinical studies have not demonstrated a statistically significant increase in broken bones among people taking semaglutide compared with placebo or other diabetes treatments.

Researchers continue to study long-term outcomes, but current evidence remains reassuring.

Who should pay extra attention to bone health?

Although Wegovy is not thought to directly weaken bones, some people have a naturally higher risk of osteoporosis and fractures.

This includes:

• adults over 65 years of age

• postmenopausal women

• people with osteoporosis

• individuals with previous fragility fractures

• people taking long-term steroid medication

• those with vitamin D deficiency

• people losing weight very rapidly

• individuals consuming very low-calorie diets

Healthcare professionals may recommend additional monitoring for these groups, including bone density (DEXA) scans where clinically appropriate.

A balanced diet help with bone density and strength

How can you protect your bones while taking Wegovy?

Supporting your bone health during weight loss is straightforward and can make a significant difference.

Prioritise protein

Aim to include a source of lean protein with each meal to help preserve muscle mass.

Get enough calcium

Include calcium-rich foods such as dairy products, fortified alternatives and leafy green vegetables where appropriate.

Maintain healthy vitamin D levels

Follow current UK guidance on vitamin D supplementation, particularly during autumn and winter or if advised by your healthcare professional.

Stay active

Regular weight-bearing exercise such as walking, alongside resistance or strength training two or three times each week, helps maintain both muscle and bone strength.

Lose weight at a steady pace

Rapid weight loss is more likely to contribute to muscle loss than gradual, sustainable weight reduction.

In conclusion...

Current evidence suggests that Wegovy does not directly reduce bone density or weaken bones.

Instead, any potential effects on bone health are more likely to arise indirectly through significant weight loss, reduced nutritional intake, loss of muscle mass and lower mechanical loading of the skeleton.

Fortunately, these risks can usually be minimised by eating a balanced diet with adequate protein, calcium and vitamin D, remaining physically active and following your clinician's advice throughout treatment.

For most people, the health benefits of achieving and maintaining a healthier weight with Wegovy are expected to outweigh any potential impact on bone health, particularly when treatment is combined with good nutrition and regular exercise.

References

• Huo Y, et al. Effects of GLP-1 receptor agonists on bone metabolism in type 2 diabetes mellitus: A systematic review and meta-analysis. Diabetes Research and Clinical Practice. 2025.

• Zhang Y, et al. Effects of GLP-1 receptor agonists on bone metabolism and its related diseases. Frontiers in Endocrinology. 2024.

• NICE. Obesity: Identification, Assessment and Management.

• Royal Osteoporosis Society. Healthy Bones – Nutrition and Lifestyle Guidance.

• NHS. Vitamin D.